ArticleBMJ open2025

Correction for 'Cost-utility analysis of MR imagingguided transurethral ultrasound ablation for the treatment of low- to intermediaterisk localised prostate cancer'.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.